Epidemiology of invasive fungal infections due to Aspergillus spp

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome J. Guinea, M. Torres-Narbona, P.

Y. Hicheri, G. Cook, C. Cordonnier Clinical Microbiology and Infection

Prevention of toxoplasmosis in transplant patients

Gut bacterial microbiota and obesity

T. Schneider, J. Halter, D. Heim, J. Passweg, M. Stern, A. Tichelli, M

D. Khalil, M. Hultin, M.U. Rashid, B. Lund

Herpes zoster in non-hospitalized children

A 1-year Aspergillus terreus surveillance study at the University Hospital of Innsbruck: molecular typing of environmental and clinical isolates G. Blum,

Migrant health—a cause for concern?

Invasive group A, B, C and G streptococcal infections in Denmark 1999–2002: epidemiological and clinical aspects K. Ekelund, P. Skinhøj, J. Madsen, H.B.

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Candida glabrata fungaemia in intensive care units

J.-P. Van geertruyden Clinical Microbiology and Infection

Y. Hicheri, G. Cook, C. Cordonnier Clinical Microbiology and Infection

Nocardiosis in Quebec, Canada, 1988–2008

Louis Pasteur, from crystals of life to vaccination

Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013 L.E.B. Nabarro, R.A. Lever, M. Armstrong,

Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice? T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt

Clinical Microbiology and Infection

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Vector control: a cornerstone in the malaria elimination campaign

J.P. Donnelly, B.E. De Pauw Clinical Microbiology and Infection

C. Girmenia, P. Guerrisi, A. M. Frustaci, A. Fama, E. Finolezzi, S

A. Solé, P. Morant, M. Salavert, J. Pemán, P. Morales

Sofie Arens, Jan Verhaegen, Ludo Verbist

Training for the infectious diseases speciality in Norway

E. Vermeulen, J. Maertens, P. Meersseman, V. Saegeman, L. Dupont, K

Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals C. Nonhoff, O. Denis,

B. Gordts Clinical Microbiology and Infection

Control of infections due to extended-spectrum β-lactamase-producing organisms in hospitals and the community R.E. Warren, G. Harvey, R. Carr, D. Ward,

S. Imbert, J.-Y. Brossas, M. Palous, I. Joly, I. Meyer, A. Fekkar

Microbiological and epidemiological studies of Enterococcus faecium resistant to amoxycillin in a university hospital in eastern France M. Thouverez,

Evolving epidemiology of invasive Haemophilus infections in the post-vaccination era: results from a long-term population-based study M.R. Berndsen,

Metagenomics and probiotics

Previously unknown species of Aspergillus

T.M. File Clinical Microbiology and Infection

Systematic review of antibiotic consumption in acute care hospitals

Update on antifungal resistance in Aspergillus and Candida

Community-acquired pneumonia: epidemiologic and clinical consideration

Abstracts cont. Clinical Microbiology and Infection

P.M. Hawkey Clinical Microbiology and Infection

Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida

Antimicrobial drug development – the past, the present, and the future

Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Listeriosis: a resurgent foodborne infection

Changing pattern of candidaemia 2001–2006 and use of antifungal therapy at the University Hospital of Vienna, Austria E. Presterl, F. Daxböck, W. Graninger,

The incidence and risk factors of invasive fungal infection after haploidentical haematopoietic stem cell transplantation without in vitro T-cell depletion

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

Z. Erjavec, H. Kluin-Nelemans, P.E. Verweij

Clinical and molecular epidemiology of chromosome-mediated resistance to third- generation cephalosporins in Enterobacter isolates in eastern France D.

The atypical pneumonias: clinical diagnosis and importance

Performance of the galactomannan antigen detection test in the diagnosis of invasive aspergillosis in children with cancer or undergoing haemopoietic.

Modelling during an emergency: the 2009 H1N1 influenza pandemic

A. Manzur, F. Gudiol Clinical Microbiology and Infection

Incidence of invasive fungal disease after unmanipulated haploidentical stem cell transplantation was significantly higher than that after HLA-matched.

W. Witte Clinical Microbiology and Infection

Update on invasive aspergillosis: clinical and diagnostic aspects

Are we losing the fight against malaria one more time?

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Three years experience of real-time PCR for the diagnosis of Q fever

L. Blairon, Y. De Gheldre, B. Delaere, A. Sonet, A. Bosly, Y

Impact of antibiotic restrictions: the patient's perspective

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Epidemiology of invasive fungal infections due to Aspergillus spp Epidemiology of invasive fungal infections due to Aspergillus spp. and Zygomycetes M.A. Sanz Alonso, I. Jarque Ramos, M. Salavert Lletí, J. Pemán Clinical Microbiology and Infection Volume 12, Pages 2-6 (December 2006) DOI: 10.1111/j.1469-0691.2006.01602.x Copyright © 2006 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Trends in fungal infections (probable and proven cases) in the Haematology Service at University Hospital La Fe over a 15-year period. Fluco-S: Fluconazole-susceptible; Fluco-R: Fluconazole-resistant. Clinical Microbiology and Infection 2006 12, 2-6DOI: (10.1111/j.1469-0691.2006.01602.x) Copyright © 2006 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 Incidence of aspergillosis in stem-cell transplant (SCT) recipients in the Haematology Service at University Hospital La Fe (1999–2003). Clinical Microbiology and Infection 2006 12, 2-6DOI: (10.1111/j.1469-0691.2006.01602.x) Copyright © 2006 European Society of Clinical Infectious Diseases Terms and Conditions